These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6382209)

  • 1. [Urinary kallikrein and plasma renin levels in patients with secondary hypertension].
    Giermakowska-Kowalik T; Kuska J; Kokot F
    Pol Tyg Lek; 1984 Mar; 39(10):325-8. PubMed ID: 6382209
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary kallikrein excretion in normal subjects and in patients with essential hypertension].
    Pierucci A; Cinotti GA; Simonetti BM; Taggi F; Ronci R; Raganelli L; Stirati G
    Minerva Nefrol; 1979; 26(1):19-23. PubMed ID: 471318
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced urinary kallikrein excretion in human renovascular hypertension caused by nonspecific aortoarteritis and other disorders.
    Dave V; Lall SB; Dash SC; Seth SD
    J Hum Hypertens; 1994 Sep; 8(9):717-23. PubMed ID: 7807503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type 1 receptor messenger RNA levels in human blood cells of patients with primary and secondary hypertension: reference to renin profile.
    Shibata H; Suzuki H; Murakami M; Sato A; Saruta T
    J Hypertens; 1994 Nov; 12(11):1275-84. PubMed ID: 7868875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urinary kallikrein excretion in primary arterial hypertension].
    Majewska Z
    Kardiol Pol; 1981; 24(10):657-64. PubMed ID: 7035733
    [No Abstract]   [Full Text] [Related]  

  • 6. Renin, kallikrein and prostaglandin renal systems in normotensive boys with and without a family history of essential hypertension.
    Rey C; Santos F; Málaga S; Orejas G; Simarro M; Crespo M
    J Cardiovasc Risk; 1995 Apr; 2(2):143-8. PubMed ID: 7606651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
    Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
    Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renin activity of blood plasma in a patient with arterial hypertension and stenosis of the renal artery].
    Lazić J; Djordjević-Denić G
    Srp Arh Celok Lek; 1982 Apr; 110(4):445-50. PubMed ID: 6761878
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary kallikrein and renovascular hypertension in rats].
    Mimran A; Baudin G; Casellas D; Wahba WK
    J Urol Nephrol (Paris); 1977 Dec; 83(12):901-6. PubMed ID: 609109
    [No Abstract]   [Full Text] [Related]  

  • 10. Clonidine in unilateral renal artery stenosis and unilateral renal parenchymal disease--similar antihypertensive but different renin suppressive effects.
    Mathias CJ; Wilkinson AH; Pike FA; Sever PS; Peart WS
    J Hypertens Suppl; 1983 Dec; 1(2):123-5. PubMed ID: 6400111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renovascular hypertension. Predictability of surgical cure of unilateral renal artery stenosis and bilateral renal artery stenosis.
    Rosenthal JT; Libertino JA
    Eur Urol; 1982; 8(2):88-93. PubMed ID: 7037421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of salt restriction and furosemide in patients investigated for renovascular hypertension.
    Mörlin C; Aberg H
    Acta Chir Scand; 1981; 147(3):169-72. PubMed ID: 7036614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary kallikrein activity (esterase activity), plasma renin activity, and urinary aldosterone excretion in kidney transplantation patients.
    Miyashita A; Sakai A; Butt KM
    Transplant Proc; 1983 Dec; 15(4):2136-8. PubMed ID: 6369681
    [No Abstract]   [Full Text] [Related]  

  • 14. Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin.
    Sealey JE; Atlas SA; Laragh JH; Oza NB; Ryan JW
    Nature; 1978 Sep; 275(5676):144-5. PubMed ID: 692685
    [No Abstract]   [Full Text] [Related]  

  • 15. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of some changes induced in the vasoactive systems of renin and kallikrein during diuretic treatment of arterial hypertension].
    Covi G; Pedrolli E; Dalla Riva S; Danti G; Lechi C; Minuz P; Mattioli M; Lechi A
    G Clin Med; 1980 Feb; 61(2):134-47. PubMed ID: 7004976
    [No Abstract]   [Full Text] [Related]  

  • 17. Kallikrein-kinin and renin-angiotensin systems in renovascular hypertension in rats.
    Vío CP; Roblero JS; Croxatto HR
    Proc Soc Exp Biol Med; 1980 Apr; 163(4):447-51. PubMed ID: 6992143
    [No Abstract]   [Full Text] [Related]  

  • 18. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary kallikrein in mild to moderate essential hypertension.
    Franchi F; Strazzulla G; Scardi A; Lo Sapio P; Fabbri G; Mannelli M; Curradi C
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():193-7. PubMed ID: 3159203
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary kallikrein excretion in hypertension.
    Margolius HS; Geller RG; De Jong W; Pisano JJ; Sjoerdsma A
    Circ Res; 1972 Sep; 31(9):Suppl 2:125-31. PubMed ID: 5057026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.